$2.500
-0.124 (-4.94%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de LIMN por análisis de gráficos similares
Alphio's LIMN stock price prediction model matches the current Liminatus Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.47 (-1.33%). The 1-week path is $2.56 (+2.27%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Liminatus Pharma Inc?
Liminatus Pharma Inc is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $2.50, which is 92.20% lower than its year-to-date performance. The RSI is at 29.815, indicating that the stock is oversold, but this is not sufficient to justify a buy given the overall financial health. The company has a forward P/E ratio of 0, suggesting no earnings growth expectations, and a gross margin of 0%, indicating no profitability. The main risk is the company's high debt-to-equity ratio of 479.85%, which poses a significant financial risk.
LIMN cerró en $2.50 el Friday, tras bajar -4.94%
Liminatus Pharma Inc (LIMN) last closed at $2.5, losing -4.94%. These facts feed the 1-day and 1-week LIMN price prediction above.
Factores de la previsión
Los factores de la previsión de Liminatus Pharma Inc (LIMN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de LIMN, ordenadas por similitud.
Análisis de estacionalidad de LIMN
Historically the probability of a positive November return for LIMN is 45.45%. January offers the highest probability of a positive month at 57.38%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de LIMN
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $5.74 | $6.00 | $6.35 | +139.96% |
| Dec 2026 | $5.09 | $5.21 | $5.42 | +108.36% |
En 2026, se proyecta que Liminatus Pharma Inc (LIMN) oscile entre $5.09 y $6.35.
Previsión mensual de Liminatus Pharma Inc para 2026
En Nov de 2026, se proyecta que Liminatus Pharma Inc promedie $6.00, con un mínimo de $5.74 y un máximo de $6.35.
En Dec de 2026, se proyecta que Liminatus Pharma Inc promedie $5.21, con un mínimo de $5.09 y un máximo de $5.42.
Artículos relacionados
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.